1 – 10 of 464
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2026
- Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapy (2026) HEALTH AND QUALITY OF LIFE OUTCOMES. 24(1).
- Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE) : a systematic review and individual patient data meta-analysis from the X-MET collaboration (2026) LANCET ONCOLOGY. 27(2). p.181-190
- Health-related quality of life outcomes of salvage metastasis-directed treatment versus elective nodal treatment for oligorecurrent nodal prostate cancer : a secondary analysis of the phase 2, open-label PEACE V–STORM randomized trial (2026) EUROPEAN UROLOGY ONCOLOGY.
- Prostate cancer (2026) LANCET. 407(10528). p.622-636
- Supportive cancer care and patient satisfaction : international prospective longitudinal study : secondary data analysis (2026) BMJ SUPPORTIVE & PALLIATIVE CARE.
- Authors' reply to : comment on 'Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer' (2026) BJU INTERNATIONAL.
- Comorbidity, treatment toxicity and satisfaction with cancer care : an international cross-sectional study based on the EORTC PATSAT-C33 and OUT-PATSAT7 (2026) SUPPORTIVE CARE IN CANCER. 34(3).
- PSMA PET/CT-guided pelvic lymph node dissection in patients with unfavorable intermediate- or high-risk prostate cancer (2026) CANADIAN JOURNAL OF UROLOGY. 33(1). p.83-92
- Pelvic lymph node dissection during radical prostatectomy for prostate cancer : harms versus benefits (2026) UROLOGIA INTERNATIONALIS. p.1-21
- Dose-intensified versus conventional-dose salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy : long-term data from the SAKK 09/10 randomised phase 3 trial (2026) EUROPEAN UROLOGY. 89(3). p.199-203